Spectrascience New Financials
Based on the key measurements obtained from Spectrascience New's financial statements, Spectrascience New is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
Spectrascience |
Please note, the presentation of Spectrascience New's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spectrascience New's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Spectrascience New's management manipulating its earnings.
Spectrascience New Stock Summary
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California. Spectrascience operates under Medical Appliances Equipment classification in the United States and is traded on OTC Exchange. It employs 5 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| ISIN | US84760E3018 |
| Business Address | 11568 Sorrento Valley |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.spectrascience.com |
| Phone | 858 847 0200 |
| Currency | USD - US Dollar |
Spectrascience New Key Financial Ratios
| Return On Asset | -0.92 | ||||
| Beta | -27.11 |
Spectrascience Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spectrascience New's current stock value. Our valuation model uses many indicators to compare Spectrascience New value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectrascience New competition to find correlations between indicators driving Spectrascience New's intrinsic value. More Info.Spectrascience New is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Spectrascience New by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Spectrascience New Systematic Risk
Spectrascience New's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Spectrascience New volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Spectrascience New correlated with the market. If Beta is less than 0 Spectrascience New generally moves in the opposite direction as compared to the market. If Spectrascience New Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Spectrascience New is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Spectrascience New is generally in the same direction as the market. If Beta > 1 Spectrascience New moves generally in the same direction as, but more than the movement of the benchmark.
About Spectrascience New Financials
What exactly are Spectrascience New Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Spectrascience New's income statement, its balance sheet, and the statement of cash flows. Potential Spectrascience New investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Spectrascience New investors may use each financial statement separately, they are all related. The changes in Spectrascience New's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Spectrascience New's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Spectrascience New March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Spectrascience New help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Spectrascience New. We use our internally-developed statistical techniques to arrive at the intrinsic value of Spectrascience New based on widely used predictive technical indicators. In general, we focus on analyzing Spectrascience Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Spectrascience New's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1307 |
Complementary Tools for Spectrascience Stock analysis
When running Spectrascience New's price analysis, check to measure Spectrascience New's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectrascience New is operating at the current time. Most of Spectrascience New's value examination focuses on studying past and present price action to predict the probability of Spectrascience New's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectrascience New's price. Additionally, you may evaluate how the addition of Spectrascience New to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |